IN2014DN10798A - - Google Patents
Info
- Publication number
- IN2014DN10798A IN2014DN10798A IN10798DEN2014A IN2014DN10798A IN 2014DN10798 A IN2014DN10798 A IN 2014DN10798A IN 10798DEN2014 A IN10798DEN2014 A IN 10798DEN2014A IN 2014DN10798 A IN2014DN10798 A IN 2014DN10798A
- Authority
- IN
- India
- Prior art keywords
- compositions
- gluten
- cba
- administered
- subject
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 4
- 108010068370 Glutens Proteins 0.000 abstract 3
- 235000021312 gluten Nutrition 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 208000015943 Coeliac disease Diseases 0.000 abstract 1
- 108010061711 Gliadin Proteins 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261661105P | 2012-06-18 | 2012-06-18 | |
| US201261725693P | 2012-11-13 | 2012-11-13 | |
| PCT/US2013/046286 WO2013192163A1 (en) | 2012-06-18 | 2013-06-18 | Gluten-related disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN10798A true IN2014DN10798A (enExample) | 2015-09-04 |
Family
ID=49769279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN10798DEN2014 IN2014DN10798A (enExample) | 2012-06-18 | 2013-06-18 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10245300B2 (enExample) |
| EP (3) | EP3901164B1 (enExample) |
| CN (1) | CN104661671B (enExample) |
| AU (2) | AU2013277316B2 (enExample) |
| BR (1) | BR112014031666B1 (enExample) |
| CA (1) | CA2876963C (enExample) |
| DK (3) | DK3351554T3 (enExample) |
| ES (3) | ES3010649T3 (enExample) |
| IN (1) | IN2014DN10798A (enExample) |
| MX (1) | MX363899B (enExample) |
| NZ (1) | NZ702936A (enExample) |
| PL (3) | PL3351554T3 (enExample) |
| PT (3) | PT3901164T (enExample) |
| RU (1) | RU2654705C2 (enExample) |
| TR (1) | TR201814973T4 (enExample) |
| WO (1) | WO2013192163A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2734049T (pt) | 2011-06-20 | 2018-07-24 | Heinz Co Brands H J Llc | Composições e métodos probióticos |
| BR112015028164B1 (pt) | 2013-05-10 | 2022-02-08 | H.J. Heinz Company Brands Llc | Usos da bactéria probiótica, lactobacillus paracasei, para tratar uma infecção microbiana e para prevenir ou reduzir a gravidade de uma infecção microbiana |
| MX2019008292A (es) * | 2017-01-12 | 2019-09-16 | Probi Ab | Composiciones probioticas y usos de las mismas. |
| CN113143973A (zh) * | 2017-03-07 | 2021-07-23 | 景岳生物科技股份有限公司 | 抗骨质流失的副干酪乳杆菌菌株gmnl-653的组合物 |
| KR102244007B1 (ko) * | 2019-02-14 | 2021-04-23 | 주식회사 메디뉴트롤 | 글루텐 분해능을 가지는 락토바실러스 파라카제이 glu70 균주를 유효성분으로 함유하는 글리아딘으로 야기된 염증성 장 질환의 예방, 개선 또는 치료용 조성물 |
| PL447563A1 (pl) * | 2024-01-22 | 2025-07-28 | Nordic Biotic Spółka Z Ograniczoną Odpowiedzialnością | Szczep Lacticaseibacillus (L.) casei LC130, szczep Lacticaseibacillus (L.) paracasei LPC100, szczep Streptococcus (S.) salivarius ssp. thermophilus ST250, kompozycja obniżająca immunoreaktywność peptydów gliadyny oraz zastosowanie szczepów do wytwarzania kompozycji |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1003929A (en) | 1911-04-04 | 1911-09-19 | Jacob T Lutz | Trace-carrier. |
| DE130228T1 (de) | 1983-07-01 | 1985-09-12 | Microlife Technics Inc., Sarasota, Fla. | Fermentierungsverfahren mit einem selektierten lactobacillus. |
| RU2134583C1 (ru) | 1996-02-29 | 1999-08-20 | Санкт-Петербургская государственная педиатрическая медицинская академия | Способ санации женщин с массивной микробной обсемененностью грудного молока |
| WO1997049303A1 (en) | 1996-06-21 | 1997-12-31 | Quest International B.V. | Fermentation of fruit products |
| SE510813C2 (sv) | 1997-12-08 | 1999-06-28 | Arla Ekonomisk Foerening | Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen |
| EP1034787A1 (en) | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactobacillus strains preventing diarrhea caused by pathogenic bacteria |
| FI110668B (fi) | 2000-06-20 | 2003-03-14 | Aboatech Ab Oy | Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn |
| SE0003100D0 (sv) | 2000-09-01 | 2000-09-01 | Probi Ab | New strains |
| KR100419132B1 (ko) | 2000-12-29 | 2004-02-18 | 조성근 | 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01 |
| AU2003215272B2 (en) * | 2002-02-14 | 2008-04-03 | The Board Of Trustees Of The Leland Stanford Junior University | Enzyme treatment of foodstuffs for celiac sprue |
| EP1364586A1 (en) | 2002-05-24 | 2003-11-26 | Nestec S.A. | Probiotics and oral tolerance |
| SI1565547T2 (sl) | 2002-06-28 | 2013-02-28 | Biosearch S.A. | Probiotiäśni sevi, postopek za izbiranje le-teh, njihovi sestavki in njihova uporaba |
| US7955834B2 (en) | 2004-06-03 | 2011-06-07 | Biogaia Ab | Method for improved breast milk feeding to reduce the risk of allergy |
| CN101365671B (zh) | 2005-12-08 | 2012-07-04 | 麒麟控股株式会社 | 异葎草酮化合物包合物及含有该包合物的组合物 |
| WO2007140622A1 (en) | 2006-06-09 | 2007-12-13 | Nutravital Inc. | Dairy-derived probiotic compositions and uses thereof |
| DE602007000193D1 (de) | 2006-07-07 | 2008-12-04 | Alpro Nv | Verfahren zur herstellung eines milchprodukt-analogs |
| CN101451158A (zh) * | 2007-12-04 | 2009-06-10 | 黑龙江大学 | 副干酪乳杆菌产生的抗菌肽的分离纯化方法 |
| EP2110027A1 (en) | 2008-04-01 | 2009-10-21 | Nestec S.A. | Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation |
| CN102065872A (zh) | 2008-05-27 | 2011-05-18 | 雀巢产品技术援助有限公司 | 改善肠微生物群的益生菌 |
| EP2138187A1 (en) | 2008-06-24 | 2009-12-30 | Nestec S.A. | Probiotics, secretory IgA and infection |
| US20100196341A1 (en) | 2009-02-05 | 2010-08-05 | Syngen Biotech Co., Ltd. | Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof |
| EP2308498A1 (en) | 2009-09-30 | 2011-04-13 | Nestec S.A. | Administration of Bifidobacterium breve during infancy to prevent inflammation later in life |
| EA031179B1 (ru) * | 2010-03-12 | 2018-11-30 | Компани Жервэ Данон | Молочнокислые бактерии, применяемые при чревной болезни |
| CN102021127B (zh) * | 2010-07-28 | 2012-05-30 | 江南大学 | 一株副干酪乳杆菌及其应用 |
| EP2449891A1 (en) | 2010-11-05 | 2012-05-09 | Nestec S.A. | Drinking yoghurt preparations containing non-replicating probiotic micro-organisms |
| EP2449890A1 (en) | 2010-11-05 | 2012-05-09 | Nestec S.A. | Powdered cereal compositions comprising non-replicating probiotic microorganisms |
| EP2455094A1 (en) | 2010-11-11 | 2012-05-23 | Nestec S.A. | Non-replicating probiotic micro-organisms protect children against gastrointestinal infections |
| EP2510932A1 (en) | 2011-04-15 | 2012-10-17 | Nestec S.A. | Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny |
| PT2734049T (pt) * | 2011-06-20 | 2018-07-24 | Heinz Co Brands H J Llc | Composições e métodos probióticos |
| KR20140088861A (ko) | 2011-09-28 | 2014-07-11 | 필립스 66 컴퍼니 | 복합 고체 산화물 연료 전지 전해질 |
| BR112015028164B1 (pt) | 2013-05-10 | 2022-02-08 | H.J. Heinz Company Brands Llc | Usos da bactéria probiótica, lactobacillus paracasei, para tratar uma infecção microbiana e para prevenir ou reduzir a gravidade de uma infecção microbiana |
-
2013
- 2013-06-18 MX MX2014015314A patent/MX363899B/es active IP Right Grant
- 2013-06-18 TR TR2018/14973T patent/TR201814973T4/tr unknown
- 2013-06-18 EP EP21165677.2A patent/EP3901164B1/en active Active
- 2013-06-18 WO PCT/US2013/046286 patent/WO2013192163A1/en not_active Ceased
- 2013-06-18 PL PL18157990T patent/PL3351554T3/pl unknown
- 2013-06-18 ES ES21165677T patent/ES3010649T3/es active Active
- 2013-06-18 DK DK18157990.5T patent/DK3351554T3/da active
- 2013-06-18 PT PT211656772T patent/PT3901164T/pt unknown
- 2013-06-18 EP EP18157990.5A patent/EP3351554B1/en active Active
- 2013-06-18 ES ES13807318.4T patent/ES2691087T3/es active Active
- 2013-06-18 CN CN201380032073.2A patent/CN104661671B/zh active Active
- 2013-06-18 BR BR112014031666-0A patent/BR112014031666B1/pt active IP Right Grant
- 2013-06-18 CA CA2876963A patent/CA2876963C/en active Active
- 2013-06-18 IN IN10798DEN2014 patent/IN2014DN10798A/en unknown
- 2013-06-18 PT PT13807318T patent/PT2861242T/pt unknown
- 2013-06-18 NZ NZ702936A patent/NZ702936A/en unknown
- 2013-06-18 ES ES18157990T patent/ES2883552T3/es active Active
- 2013-06-18 DK DK13807318.4T patent/DK2861242T3/en active
- 2013-06-18 PT PT181579905T patent/PT3351554T/pt unknown
- 2013-06-18 EP EP13807318.4A patent/EP2861242B1/en active Active
- 2013-06-18 RU RU2014150934A patent/RU2654705C2/ru active
- 2013-06-18 PL PL21165677.2T patent/PL3901164T3/pl unknown
- 2013-06-18 PL PL13807318T patent/PL2861242T3/pl unknown
- 2013-06-18 AU AU2013277316A patent/AU2013277316B2/en active Active
- 2013-06-18 US US14/408,108 patent/US10245300B2/en active Active
- 2013-06-18 DK DK21165677.2T patent/DK3901164T3/da active
-
2018
- 2018-05-21 AU AU2018203543A patent/AU2018203543B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ708727A (en) | Conjugate compounds | |
| MX2014003288A (es) | Preparacion y composiciones de azufre con valencia cero, altamente bio-disponibles, y sus usos. | |
| MX2013004061A (es) | Analogos de ciclosporina. | |
| AU2012253759A8 (en) | Tricyclic sulfonamide compounds and methods of making and using same | |
| EA033689B9 (ru) | Ингибиторы g12c kras | |
| PH12013502240B1 (en) | Novel compounds as modulators of protein kinase | |
| IN2014DN09805A (enExample) | ||
| EP4414376A3 (en) | Novel depsipeptide and uses thereof | |
| MX2013010376A (es) | Formulaciones estables para inyeccion parenteral de farmacos de peptido. | |
| NZ702936A (en) | Gluten-related disorders | |
| WO2013022991A3 (en) | Methods and compositions relating to p62 for the treatment and prophylaxis of cancer | |
| MX2014008705A (es) | Compuestos tricíclicos de sulfona y métodos para elaborarlos y utilizarlos. | |
| MX2015000338A (es) | Novedosa cepa de lactobacillus crispatus. | |
| EP4371612A3 (en) | Nutritional product | |
| PH12014502537A1 (en) | Therapeutic uses of fibroblast growth factor 21 proteins | |
| MX2014008706A (es) | Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos. | |
| MX348708B (es) | Métodos para mejorar el desarrollo del cerebro y la función cognoscitiva al usar beta-hidroxi-beta-metilbutirato. | |
| IN2015MN00027A (enExample) | ||
| MX2013008500A (es) | Disialillacto-n-tetraosa (dslnt) o variantes, isomeros, analogos y derivados de la misma para prevenir o inhibir la enfermedad del intestino. | |
| MX2013005351A (es) | Particulas inmuno-moduladoras modificadas. | |
| EA201591758A1 (ru) | Подкожное введение adamts13 | |
| MX2013004062A (es) | Analogos de ciclosporina. | |
| MX2016006544A (es) | Witanolidos utiles para el tratamiento de enfermedades neurodegenerativas. | |
| MX2013013649A (es) | Compuestos de quinona para tratar enfermedades mediadas por ape1. | |
| IN2015DN04209A (enExample) |